Cosign Ai

Breakthrough science deserves breakthrough timelines. Yet clinical development is often defined by delay: burdensome manual work, missed patients, high screen failures and slow recruitment. Every month lost means patients wait, and costs balloon. It has even been estimated that 85% of clinical trials fall behind schedule—costing sponsors up to $8 million a day in lost revenue. Cosign AI enables investigators and clinical sites to identify eligible patients in real time at the point of care. Our technology surfaces the right candidates for the right trials - effortlessly, accurately, and without disrupting clinical workflows. Let’s explore the possibilities.